Obermatt
See Similar Stocks →

Protara Therapeutics

NMQ:TARA · US74365U1079
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings39
Price/Book64
Dividend Yield—
Revenue Growth—
Profit Growth71
Capital Growth97
TSR 52w42
Leverage76
Liquidity30
Refinancing43
Combined—
Analyst Opinions61
Pro Holdings71
Opinion Changes50
Market Pulse79

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Employees45
Websiteprotaratx.com
ISINUS74365U1079
Last UpdateApr 2, 2026
Index & Theme
UrologyImmunologyChronic DiseasesHepatologyOncologyHealth CareMedicalTherapeutics

Description

Protara Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to advancing transformative therapies for the treatment of cancer and rare diseases. The company prioritizes creativity, integrity and tenacity to expedite its intent…

Similar Stocks

The companies this stock is ranked against.

Compare Protara Therapeutics with its peers
Palvella Therapeutics
NAQ:PVLA
100
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Adaptive Biotechnologies
NSQ:ADPT
20
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →
Taysha Gene Therapies
NSQ:TSHA
21
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Soleno Therapeutics
NAQ:SLNO
67
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Kyverna Therapeutics
NSQ:KYTX
6
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Aura Biosciences
NMQ:AURA
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →